Basic Information | Post buying leads | Suppliers |
Name |
Dehydrostilbestrol |
EINECS | 201-519-7 |
CAS No. | 84-17-3 | Density | 1.129 g/cm3 |
PSA | 40.46000 | LogP | 4.60460 |
Solubility | 3mg/L(37 oC) | Melting Point |
229 °C |
Formula | C18H18 O2 | Boiling Point | 395.4 °C at 760 mmHg |
Molecular Weight | 266.34 | Flash Point | 181.4 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Suspected human carcinogen. Human mutation data reported. Experimental reproductive effects. Used as a drug for the treatment of postmenopausal symptoms. When heated to decomposition it emits acrid smoke and irritating fumes. | Risk Codes | 40-48 |
Molecular Structure | Hazard Symbols | Xn | |
Synonyms |
Phenol,4,4'-(diethylideneethylene)di- (7CI,8CI); 2,4-Hexadiene,3,4-bis(4-hydroxyphenyl)-; 3,4-Bis(p-hydroxyphenyl)-2,4-hexadiene;3,4-Di-p-(hydroxyphenyl)hexa-2,4-diene; 4,4'-(Diethylideneethylene)diphenol;4,4'-Dihydroxy-g,d-diphenyl-b,d-hexadiene; Cycladiene; DV;Di-(p-oxyphenyl)-2,4-hexadiene; Dienesterol; Dienestrol; Dienoestrol; Dienol;Dinovex; Estrodienol; Estroral; Follidiene; Follormon; Gynefollin; Hormofemin;NSC 59809; Oestrasid; Oestrodiene; Oestroral; Restrol; Retalon; Sexadien;Synestrol; Teserene; p,p'-(Diethylideneethylene)diphenol |
Chemical Name: Dienestrol
IUPAC NAME: 4-[(2E,4E)-4-(4-Hydroxyphenyl)hexa-2,4-dien-3-yl]phenol
CAS No.: 84-17-3
EINECS: 201-519-7
RTECS: SL0580000
Molecular Formula: C18H18O2
Molecular Weight: 266.33 g/mol
Melting Point: 229 °C
Density: 1.129 g/cm3
Flash Point: 181.4 °C
Boiling Point: 395.4 °C at 760 mmHg
Following is the structure of Dehydrostilbestrol (84-17-3):
The chemical synonymous of Dehydrostilbestrol (84-17-3) are 3,4-Bis(4-hydroxyphenyl)-2,4-hexadiene ; 3,4-Di(p-oxyphenyl)-2 4-hexadiene ; 4,4'-Dihydroxy-gamma,delta-diphenyl-beta,delta-hexadiene ; 4,4'-(Diethylideneethylene)diphenol ; Dienestrol ; Cycladiene ; 2,4-Hexadiene, 3,4-bis(4-hydroxyphenyl)-
1. | sce-hmn:fbr 5 nmol/L | NATUAS Nature. 281 (1979),392. | ||
2. | dns-ham:emb 3 mg/L | CNREA8 Cancer Research. 44 (1984),184. |
IARC Cancer Review: Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 21 (1979),p. 161.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 21 (1979),p. 161.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) .
Suspected human carcinogen. Human mutation data reported. Experimental reproductive effects. Used as a drug for the treatment of postmenopausal symptoms. When heated to decomposition it emits acrid smoke and irritating fumes.
Hazard Codes:
Xn: Harmful
Risk Statements about Dehydrostilbestrol (84-17-3):
R40 Limited evidence of a carcinogenic effect.
R48 Danger of serious damage to health by prolonged exposure.
Safety Statements about Dehydrostilbestrol (84-17-3):
S22 Do not breathe dust.
S24/25: Avoid contact with skin and eyes.